To investigate the association of functional variants of the human UNC13A gene with the risk of ALS, survival and the disease progression rate in a Spanish ALS cohort. 136 sporadic ALS (sALS) patients and 487 healthy controls were genotyped for the UNC13A rs12608932 variant. Clinical characterization of ALS patients included gender, age at first symptom, initial topography, disease progression rate, and survival. Genetic association was analyzed under five inheritance models. The sALS patients with the rs12608932 CC genotype had an increased risk of ALS under a recessive genetic model OR 2.16; 95 % CI (1.23, 3.8), p  = 0.009; corrected p  = 0.028. Genotypes with a C allele are also associated with increased risk OR 1.47; 95 % CI (1.11, 1.95); p  = 0.008; corrected p  = 0.023 under an additive model. sALS patients with a C/C genotype had a shorter survival than patients with A/A and A/C genotypes HR 1.44; 95 % CI (1.11, 1.873); p  = 0.007 under a recessive model. In an overdominant model, heterozygous patients had a longer survival than homozygous patients HR 0.36; 95 % CI (0.22, 0.59); p  = 0.001. The rs12608932 genotypes modify the progression of symptoms measured using the ALSFRS-R. No association with age of onset, initial topography or rate of decline in FVC was found. Our results show that rs12608932 is a risk factor for ALS in the Spanish population and replicate the findings described in other populations. The rs12608932 is a modifying factor for survival and disease progression rate in our series. Our results also corroborated that it did not influence the age of onset.